Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AnaptysBio Inc ANAB

Healthcare Biotechnology
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on delivering immunology therapeutics. The Company is developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis; and ANB032... see more

Recent & Breaking News (NDAQ:ANAB)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB

ACCESSWIRE IA May 25, 2020

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AnaptysBio, Inc. (ANAB)

Business Wire May 25, 2020

ANAB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 26, 2020 in the Class Action Filed on Behalf of AnaptysBio, Inc. Limited Shareholders

Newsfile May 25, 2020

DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 25, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AnaptysBio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 26, 2020 - ANAB

Newsfile May 25, 2020

MAY 26 FINAL DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 24, 2020

ANAB DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100,000 of Class Action and Lead Plaintiff Deadline: May 26, 2020

ACCESSWIRE IA May 24, 2020

A LEADING LAW FIRM, ROSEN, Reminds Anaptysbio, Inc. Investors to Contact Firm BEFORE Important May 26 Deadline in Securities Class Action Seeking Recovery of Investor Losses - ANAB

ACCESSWIRE IA May 23, 2020

IMPORTANT TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 23, 2020

ANAPTYSBIO 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB

Business Wire May 22, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB

ACCESSWIRE IA May 22, 2020

DEADLINE ALERT for ANAB, DOYU, HAFC, and HFFG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire May 22, 2020

4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 22, 2020

ANAB DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100,000 of Class Action and Lead Plaintiff Deadline: May 26, 2020

ACCESSWIRE IA May 22, 2020

ANAB FINAL DEADLINE TUESDAY: ROSEN, A TOP RANKED INVESTOR FIRM, Reminds AnaptysBio, Inc. Investors of Important May 26 Deadline in Securities Class Action

Business Wire May 22, 2020

ANAB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 26, 2020 in the Class Action Filed on Behalf of AnaptysBio, Inc. Limited Shareholders

Newsfile May 22, 2020

TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 22, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB

GlobeNewswire May 21, 2020

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AnaptysBio, Inc. Investors (ANAB)

Business Wire May 21, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AnaptysBio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 26, 2020 - ANAB

Newsfile May 21, 2020